Skip to main content
VIYASH SCIENTIFIC LIMITED logo

VIYASH SCIENTIFIC LIMITED — Investor Relations & Filings

Ticker · VIYASH ISIN · INE807F01027 LEI · 335800SXM7D3VSHF2X07 BSE.NS Manufacturing
Open in API
Filings indexed 1,424 across all filing types
Latest filing 2026-06-08 M&A Activity
Country IN India
Listing BSE.NS VIYASH

About VIYASH SCIENTIFIC LIMITED

https://www.viyash.com

Viyash Scientific Limited is an integrated pharmaceutical platform specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), advanced intermediates, and finished dosage forms. The organization operates a network of manufacturing facilities supported by robust research and development capabilities, focusing on complex chemistry and niche therapeutic segments. Its core business activities encompass the entire pharmaceutical value chain, from process development and scale-up to commercial-scale production. The company provides integrated solutions to global partners, leveraging its technical expertise in chemical synthesis and commitment to international quality standards. By maintaining a focus on operational excellence and innovation, the company serves as a strategic partner in the global healthcare supply chain, delivering high-quality medicinal components and formulations.

Recent filings

Filing Released Lang Actions
Press Release
M&A Activity Classification · 91% confidence The document is a stock exchange filing under SEBI LODR, notifying investors of Viyash Scientific’s acquisition of Italy’s BioForLife. It is not a report of financial results or regulatory certification; rather, it is an announcement of a strategic merger/acquisition transaction. This matches the “M&A Activity” category (Code: TAR), which covers announcements and documents related to merger proposals, takeover bids, and acquisitions.
2026-06-08 English
General Updates
M&A Activity Classification · 87% confidence The document is a stock exchange disclosure under SEBI Listing Regulations (Regulation 30) announcing the acquisition of 100% shareholding of BioForLife Italia s.r.l. by Viyash’s subsidiary. It provides transaction details, consideration, conditions precedent, regulatory approvals, and background on the target. This is a merger & acquisition announcement rather than a financing update, management change, or standalone report, fitting the M&A Activity category.
2026-06-08 English
Press Release
M&A Activity Classification · 92% confidence The document is a press release filed under SEBI (Listing Obligations and Disclosure Requirements) Regulations announcing Viyash Scientific’s binding agreement to acquire 100% stake in Italy’s BioForLife. It is a corporate announcement of an acquisition transaction, fitting the “M&A Activity” category (Code: TAR).
2026-06-08 English
We hereby inform you that AAHL Ireland, Stepdown wholly owned subsidiary of the Company has entered into a Binding agreement today i.e. June 08, 2026 for acquisition of 100% shareholding ....
M&A Activity Classification · 85% confidence The document is an official intimation under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, notifying the stock exchanges of the company’s subsidiary’s binding agreement to acquire 100% of BioForLife Italia. It contains transaction details (consideration, timeline, background) and meets the definition of an M&A activity announcement rather than a full proxy statement or financial report. Therefore it is classified as M&A Activity (TAR).
2026-06-08 English
Newspaper Publication
Regulatory Filings Classification · 82% confidence The document is a short formal letter addressed to BSE and NSE under SEBI Listing Regulations, notifying the publication in newspaper of the dispatch of a Notice of Postal Ballot. It does not contain actual financial statements or voting results, nor the full proxy/material itself but is a regulatory compliance announcement. Therefore it best fits the “Regulatory Filings” category (RNS).
2026-05-30 English
Copy of Newspaper Publication
Regulatory Filings Classification · 83% confidence The document is a short letter dated May 30, 2026 from Viyash Scientific Limited to the BSE and NSE under Regulation 30 of SEBI LODR, enclosing copies of a newspaper advertisement confirming dispatch of the Notice of Postal Ballot. It is an intimation/announcement to stock exchanges rather than the full proxy materials or voting results. It falls under general regulatory filings (Regulatory Filings) rather than a substantive report, proxy statement, or results declaration.
2026-05-30 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.